US Stock Futures Mostly Flat; Jobless Claims Data In Focus - Bristol-Myers Squibb (NYSE:BMY)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Pre-open moversUS stock futures were mostly flat in early pre-market trade, ahead of jobless claims data. Data on weekly jobless claims, and import and export prices for August will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average dropped 6 points to 15,324.00, while the Standard & Poor's 500 index futures fell 1.25 points to 1,687.50. Futures for the Nasdaq 100 index rose 1 point to 3,179.50.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global Markets European markets were mostly lower today, with the Spanish Ibex Index rising 0.09%, London's FTSE 100 index dropping 0.23% and STOXX Europe 600 Index declining 0.22%. German DAX 30 index fell 0.20% and French CAC 40 Index declined 0.33%. Euro-zone industrial production dropped 1.5% in July from June. Italy's industrial production fell 1.1% on the month in July. French consumer price index increased 0.5% in August versus the prior month.Asian markets ended mostly higher today. China's Shanghai Composite rose 0.64%, while Japan's Nikkei Stock Average fell 0.26%. Australia's ASX/S&P500 gained 0.15% and Hong Kong's Hang Seng Index rose 0.07% and India's Sensex dropped 1.08%. Australia's unemployment rate increased to 5.8% in August, versus 5.7% in July. However, economists were projecting an unemployment rate of 5.8%. Broker Recommendation

Analysts at Morgan Stanley downgraded Netflix (NASDAQ: NFLX) from “overweight” to “equal-weight.” Netflix's shares closed at $308.30 yesterday. Breaking news

Bristol-Myers Squibb Company (NYSE: BMY) today reported results from the Phase 3 randomized, double-blind clinical trial (Study 043) comparing Yervoy 10 mg/kg (ipilimumab) (n=399) to placebo (n=400) following radiation in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) who have received prior treatment with docetaxel. To read the full news, click here.
Dunkin' Donuts (NASDAQ: DNKN) today announced that it has signed agreements with two franchise groups to begin developing Dunkin' Donuts restaurants in the United Kingdom. To read the full news, click here.
Chambers Street Properties (NYSE: CSG) announced today that its board of trustees has approved a monthly distribution to shareholders of $0.042 per common share for October 2013, representing an annualized amount of approximately $0.504 per share. To read the full news, click here.
Sunshine Heart (NASDAQ: SSH) announced today the first patient implant in the Company's U.S. pivotal trial, COUNTER HF. To read the full news, click here.